Intra-Cellular Therapies, Inc. (ITCI)

Intra-Cellular Therapies Market Cap

Intra-Cellular Therapies has a market cap or net worth of $6.95 billion as of April 25, 2024. Its market cap has increased by 15.46% in one year.

• Market Cap: 6.95B
• Enterprise Value: 6.60B
• 1-Year Change: 15.46%
• Ranking: #998
• Category: Mid-Cap
• Stock Price: $71.87

Market Cap Chart

Since January 7, 2014, Intra-Cellular Therapies's market cap has increased from $332.00M to $6.95B, an increase of 1,993.46%. That is a compound annual growth rate of 34.36%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	7.16B	-0.71%
Apr 22, 2024	7.22B	3.00%
Apr 19, 2024	7.01B	0.51%
Apr 18, 2024	6.97B	-6.12%
Apr 17, 2024	7.42B	-3.95%
Apr 16, 2024	7.73B	23.29%
Apr 15, 2024	6.27B	-1.70%
Apr 12, 2024	6.38B	-3.07%
Apr 11, 2024	6.58B	1.03%
Apr 10, 2024	6.51B	-1.95%
Apr 9, 2024	6.64B	1.36%
Apr 8, 2024	6.55B	-1.08%
Apr 5, 2024	6.63B	1.83%
Apr 4, 2024	6.51B	-0.16%
Apr 3, 2024	6.52B	0.98%
Apr 2, 2024	6.45B	-2.34%
Apr 1, 2024	6.61B	-1.34%
Mar 28, 2024	6.70B	-0.75%
Mar 27, 2024	6.75B	3.55%
Mar 26, 2024	6.52B	-0.94%
Mar 25, 2024	6.58B	-1.52%
Mar 22, 2024	6.68B	0.94%
Mar 21, 2024	6.62B	1.74%
Mar 20, 2024	6.51B	2.69%
Mar 19, 2024	6.34B	0.12%

View and export this data all the way back to 2014. Sign Up Today.

Related Stocks

Company	Market Cap
Bio-Rad Laboratories	7.91B
Cerevel Therapeutics Holdings	7.63B
Masimo	7.18B
Viking Therapeutics	7.13B
Inspire Medical Systems	7.11B
Cytokinetics	7.00B
Exelixis	7.00B
Globus Medical	6.94B